Company Performance Metrics
Owkin develops agentic AI platforms and biological reasoning models to analyze complex patient data and support medical research. The company offers K Pro, an AI agent that helps biopharma teams generate insights and make decisions across drug discovery and clinical development. Owkin provides data licensing services, giving access to richly
described multimodal patient datasets across several therapeutic indications and modalities. Its AI drug development solutions include external control arms, inclusion criteria models, and data-driven covariate adjustment to optimize clinical trials. Owkin also builds AI tools for digital pathology and diagnostics and collaborates in consortia such as MOSAIC and PortrAIt to develop AI-enabled approaches to precision medicine.
